Westlake BioPartners Opportunity Fund I, L.P., 10% Owner at Kyverna Therapeutics, Inc. (KYTX), bought 266,666 shares at $7.50 ($2.0M) on 2025-12-18, disclosed to the SEC on 2025-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 133,333 | $1000K | 50.0% |
| 2 | $7.50 | 133,333 | $1000K | 50.0% |
| Total | $7.50 avg | 266,666 | $2.0M | 100% |